| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.965423 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20260911134824 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn |||||||| |
|---|
| 008 | 260825e202609##onc o f000 0 eng d |
|---|
| 020 | |a9781100003306 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-250/2026E-PDF |
|---|
| 245 | 00|aGuidance on notifying Health Canada of foreign actions. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |cSeptember 2026. |
|---|
| 264 | 4|a©2026 |
|---|
| 300 | |a1 online resource (ii, 19 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : aviser Santé Canada des mesures prises à l'étranger. |
|---|
| 520 | |a"Many drugs may be marketed years in advance or prescribed in higher volume in other countries. For this reason, important safety signals may be detected earlier in a foreign jurisdiction. The foreign notification provisions make it possible for us to know early on about regulatory actions taken in foreign jurisdictions"--page 1. |
|---|
| 610 | 10|aCanada. |tFood and Drugs Act. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 650 | 0|aPharmacovigilance|xGovernment policy|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.965422 |
|---|
| 856 | 40|qPDF|s666 KB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/H164-250-2026-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/notifying-foreign-action.html |
|---|
| 986 | |a260267 |
|---|